Using artificial intelligence (AI), scientists in the United States and Canada have discovered that a new antibiotic, Abaucin, can kill the deadly superbug Acinetobacter baumannii. This new antibiotic has yet to be further experimentally verified. It is expected that the first batch of AI antibiotics may not be available for prescription until 2030, but this study has demonstrated the great potential of AI in the fields of science and medicine.
A postgraduate student at McMaster University in Canada who participated in the research.
According to the latest research published in the scientific journal Nature Chemical Biology, a group of scientists from McMaster University in Canada and the Massachusetts Institute of Technology in the United States used AI algorithms to screen thousands of antibacterial molecules in an attempt to predict new structural categories, This allowed the researchers to identify a new antibacterial compound, Abaucin, that could be used against Acinetobacter baumannii.
The scientists then tested the new antimicrobial compound against Acinetobacter baumannii in a wound infection model in mice and found that the molecule inhibited the infection.
Stokes, an assistant professor in the Department of Biomedicine and Biochemistry at McMaster University who helped lead the study, said: “This work validates the benefits of machine learning in finding new antibiotics. With AI, we can quickly explore huge chemical field, greatly increasing the chances of discovering new antibacterial molecules.”
read more articles
2023-05-27 07:09:32
#discover #antibiotic #scientists #deal #deadly #superbugs
